UCFA
ARNA

United Capital Financial Advisors’s Arena Pharmaceuticals Inc ARNA Stock Holding History

United Capital Financial Advisors’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-2,310
Closed -$146K – 956
2014
Q1 		$146K Buy
+2,310
New +$153K ﹤0.01% 897
2013
Q4 		– Sell
-2,150
Closed -$113K – 784
2013
Q3 		$113K Hold
2,150
– – ﹤0.01% 663
2013
Q2 		$166K Buy
+2,150
New +$176K ﹤0.01% 667

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 17.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

United Capital Financial Advisors's ARNA Position: Q2 2014 in Review

United Capital Financial Advisors sold out of Arena Pharmaceuticals Inc (ARNA) in Q2 2014, closing a stake of 2,310 shares — an estimated $146K sold.

United Capital Financial Advisors first reported a position in ARNA in Q2 2013 and held it in 3 quarters. The position peaked at $166K in Q2 2013. 129 funds tracked by Wall St. Rank hold ARNA as of Q2 2014.

  • United Capital Financial Advisors reported no remaining Arena Pharmaceuticals Inc position as of Q2 2014 after selling out during the quarter.
  • United Capital Financial Advisors sold 2,310 Arena Pharmaceuticals Inc shares in Q2 2014, an estimated $146K.
  • United Capital Financial Advisors first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 3 quarters.
  • United Capital Financial Advisors's Arena Pharmaceuticals Inc position peaked at $166K in Q2 2013.
  • 129 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q2 2014.

Based on United Capital Financial Advisors's 13F filing for Q2 2014, filed 13 Aug 2014.